Article

Joint mechanistic modeling of viral and antibody responses to vaccines in non-human primates to quantify SARS-CoV-2 mechanistic correlates of protection

2026-01-16

Abstract excerpt

In a global SARS-CoV-2 landscape of hybrid immunity resulting from a vaccinated worldwide population and the emergence of new variants able to escape immunity, the identification and quantification of correlates of protection (CoPs) is crucial for the adaptation of next-generation SARS-CoV-2 vaccines. Antibodies and their neutralizing capacity have been identified as reliable mechanistic CoPs. Here, we proposed an...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fc83e5aa-775d-5ddb-96b5-5b48ae5e4182
DOI: 10.64898/2026.01.15.699647

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Joint mechanistic modeling of viral and antibody responses to vaccines in non-human primates to quantify SARS-CoV-2 mechanistic correlates of protectionDOI 10.64898/2026.01.15.699647Read

SARS-CoV-2 mechanistic correlates of protection: insight from modelling response to vaccinesSemantic proximity Read

Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccinationSemantic proximity Read

Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccinationSemantic proximity Read

Predicting antibody kinetics and duration of protection against SARS-CoV-2 following vaccination from sparse serological dataSemantic proximity Read

Insights into B Cell and Antibody Kinetics Against SARS-CoV-2 Variants Using Mathematical ModellingSemantic proximity Read

Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaquesSemantic proximity Read

Explicit Modelling of Antibody Levels for Infectious Disease Simulations in the Context of SARS-CoV-2Semantic proximity Read

Collaboration between the Fab and Fc Contribute to Maximal Protection Against SARS-CoV-2 Following NVX-CoV2373 Subunit Vaccine with Matrix-M™ VaccinationSemantic proximity Read

Quantification of the IgG antibody response half-life for hybrid immunity to SARS-CoV-2Semantic proximity Read

Integrative Modeling of SARS-CoV-2 Infection Dynamics to Inform COVID-19 Vaccination StrategiesSemantic proximity Read

Predicting COVID-19 Vaccine Efficacy from Neutralizing Antibody LevelsSemantic proximity Read

The Impact of SARS-CoV-2 Vaccination and Infection on Neutralising Antibodies: A Nation-Wide Cross-Sectional AnalysisSemantic proximity Read